Join
Live feed
·
PRReleasevia Quantisnow
Nexalin Technology Inc. logo

Nexalin Technology Announces Issuance of U.S. Patent Covering Dynamic Frequency Stimulation for Anxiety, Depression and Insomnia

ByQuantisnow·Wall Street's wire, on your screen.
NXL· Nexalin Technology Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track NXL (Nexalin Technology Inc.) and more on Quantisnow.